Innate and adaptive immune interactions at the fetal-maternal interface in healthy human pregnancy and pre-eclampsia

Frontiers in Immunology

Volumn 5, Issue MAR, 2014, Pages

  Hsu, Peter ^a,b,c   Nanan, Ralph Kay Heinrich ^a,c  

^a Charles Perkins Centre Nepean   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Decidual; Dendritic cells; NK cells; Pre eclampsia; Pregnancy; T regulatory cells

Indexed keywords

ANGIOPOIETIN 2; B7 ANTIGEN; CD123 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; CD209 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD83 ANTIGEN; CHEMOKINE RECEPTOR CCR7; COLONY STIMULATING FACTOR 1; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; HLA G ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; NEUROPILIN; PLACENTAL GROWTH FACTOR; SECONDARY LYMPHOID TISSUE CHEMOKINE; T6 ANTIGEN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN C;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; CELL DIFFERENTIATION; DECIDUA; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MICROARRAY ANALYSIS; MOTHER FETUS RELATIONSHIP; NONHUMAN; PREECLAMPSIA; PREGNANCY; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; TROPHOBLAST;

EID: 84897947726     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00125     Document Type: Review

References (128)

1. Medawar PB. Some immunological and endocrinological problems raised by evolution of viviparity in vertebrates. Symp Soc Exp Biol (1953) 7:320-8.
2. Apps R, Murphy SP, Fernando R, Gardner L, Ahad T, Moffett A. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology (2009) 127(1):26-39. doi:10.1111/j.1365-2567.2008.03019.x
3. Nelson JL. Microchimerism: incidental byproduct of pregnancy or active participant in human health? Trends Mol Med (2002) 8(3):109-13. doi:10.1016/S1471-4914(01)02269-9
4. Nelson JL. Microchimerism in human health and disease. Autoimmunity (2003) 36(1):5-9. doi:10.1080/0891693031000067304
5. Morin-Papunen L, Tiilikainen A, Hartikainen-Sorri AL. Maternal HLA immunization during pregnancy: presence of anti HLA antibodies in half of multigravidous women. Med Biol (1984) 62(6):323-5.
6. Lee J, Romero R, Xu Y, Miranda J, Yoo W, Chaemsaithong P, et al. Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery. Am J Reprod Immunol (2013) 70(2):162-75. doi:10.1111/aji.12141
7. Erlebacher A, Vencato D, Price KA, Zhang D, Glimcher LH. Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest (2007) 117(5):1399-411. doi:10.1172/JCI28214
8. Geiselhart A, Dietl J, Marzusch K, Ruck P, Ruck M, Horny HP, et al. Comparative analysis of the immunophenotypes of decidual and peripheral blood large granular lymphocytes and T cells during early human pregnancy. Am J Reprod Immunol (1995) 33(4):315-22. doi:10.1111/j.1600-0897.1995.tb00900.x
9. Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol (2010) 63(6):534-43. doi:10.1111/j.1600-0897.2010.00831.x
10. Wilczynski JR. Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia-the same basic mechanism? Hum Immunol (2006) 67(7):492-511. doi:10.1016/j.humimm.2006.04.007
11. Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol (2010) 5:173-92. doi:10.1146/annurev-pathol-121808-102149
12. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens (1991) 4(8):700-8.
13. Gardner L, Moffett A. Dendritic cells in the human decidua. Biol Reprod (2003) 69(4):1438-46. doi:10.1095/biolreprod.103.017574
14. Ban YL, Kong BH, Qu X, Yang QF, Ma YY. BDCA-1+, BDCA-2+ and BDCA-3+ dendritic cells in early human pregnancy decidua. Clin Exp Immunol (2008) 151(3):399-406. doi:10.1111/j.1365-2249.2007.03576.x
15. Kammerer U, Schoppet M, McLellan AD, Kapp M, Huppertz HI, Kampgen E, et al. Human decidua contains potent immunostimulatory CD83(+) dendritic cells. Am J Pathol (2000) 157(1):159-69. doi:10.1016/S0002-9440(10)64527-0
16. Laskarin G, Redzovic A, Rubesa Z, Mantovani A, Allavena P, Haller H, et al. Decidual natural killer cell tuning by autologous dendritic cells. Am J Reprod Immunol (2008) 59(5):433-45. doi:10.1111/j.1600-0897.2008.00599.x
17. Miyazaki S, Tsuda H, Sakai M, Hori S, Sasaki Y, Futatani T, et al. Predominance of Th2-promoting dendritic cells in early human pregnancy decidua. J Leukoc Biol (2003) 74(4):514-22. doi:10.1189/jlb.1102566
18. Plaks V, Birnberg T, Berkutzki T, Sela S, BenYashar A, Kalchenko V, et al. Uterine DCs are crucial for decidua formation during embryo implantation in mice. J Clin Invest (2008) 118(12):3954-65. doi:10.1172/JCI36682
19. Collins MK, Tay C-S, Erlebacher A. Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in mice. J Clin Invest (2009) 119(7):2062-73. doi:10.1172/JCI38714
20. Red-Horse K, Drake PM, Fisher SJ. Human pregnancy: the role of chemokine networks at the fetal-maternal interface. Expert Rev Mol Med (2004) 6(11):1-14. doi:10.1017/S1462399404007720
21. Red-Horse K. Lymphatic vessel dynamics in the uterine wall. Placenta (2008) 29(Suppl A):S55-9. doi:10.1016/j.placenta.2007.11.011
22. Huang SJ, Chen CP, Schatz F, Rahman M, Abrahams VM, Lockwood CJ. Pre-eclampsia is associated with dendritic cell recruitment into the uterine decidua. J Pathol (2008) 214(3):328-36. doi:10.1002/path.2257
23. Scholz C, Toth B, Santoso L, Kuhn C, Franz M, Mayr D, et al. Distribution and maturity of dendritic cells in diseases of insufficient placentation. Am J Reprod Immunol (2008) 60(3):238-45. doi:10.1111/j.1600-0897.2008.00619.x
24. Hume DA. The mononuclear phagocyte system. Curr Opin Immunol (2006) 18(1):49-53. doi:10.1016/j.coi.2005.11.008
25. Hume DA. Macrophages as APC and the dendritic cell myth. J Immunol (2008) 181(9):5829-35.
26. Bulmer JN, Johnson PM. Macrophage populations in the human placenta and amniochorion. Clin Exp Immunol (1984) 57(2):393-403.
27. Heikkinen J, Mottonen M, Komi J, Alanen A, Lassila O. Phenotypic characterization of human decidual macrophages. Clin Exp Immunol (2003) 131(3):498-505. doi:10.1046/j.1365-2249.2003.02092.x
28. Repnik U, Tilburgs T, Roelen DL, van der Mast BJ, Kanhai HH, Scherjon S, et al. Comparison of macrophage phenotype between decidua basalis and decidua parietalis by flow cytometry. Placenta (2008) 29(5):405-12. doi:10.1016/j.placenta.2008.02.004
29. Gustafsson C, Mjosberg J, Matussek A, Geffers R, Matthiesen L, Berg G, et al. Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS One (2008) 3(4):e2078. doi:10.1371/journal.pone.0002078
30. Mizuno M, Aoki K, Kimbara T. Functions of macrophages in human decidual tissue in early pregnancy. Am J Reprod Immunol (1994) 31(4):180-8. doi:10.1111/j.1600-0897.1994.tb00865.x
31. Parhar RS, Kennedy TG, Lala PK. Suppression of lymphocyte alloreactivity by early gestational human decidua. I. Characterization of suppressor cells and suppressor molecules. Cell Immunol (1988) 116(2):392-410. doi:10.1016/0008-8749(88)90240-7
32. Smith SD, Dunk CE, Aplin JD, Harris LK, Jones RL. Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am J Pathol (2009) 174(5):1959-71. doi:10.2353/ajpath.2009.080995
33. Cheong C, Matos I, Choi J-H, Dandamudi DB, Shrestha E, Longhi MP, et al. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell (2010) 143(3):416-29. doi:10.1016/j.cell.2010.09.039
34. Nagamatsu T, Schust DJ. The immunomodulatory roles of macrophages at the maternal-fetal interface. Reprod Sci (2010) 17(3):209-18. doi:10.1177/1933719109349962
35. Rieger L, Segerer S, Bernar T, Kapp M, Majic M, Morr A-K, et al. Specific subsets of immune cells in human decidua differ between normal pregnancy and preeclampsia-a prospective observational study. Reprod Biol Endocrinol (2009) 7:132. doi:10.1186/1477-7827-7-132
36. Schonkeren D, van der Hoorn M-L, Khedoe P, Swings G, van Beelen E, Claas F, et al. Differential distribution and phenotype of decidual macrophages in preeclamptic versus control pregnancies. Am J Pathol (2011) 178(2):709-17. doi:10.1016/j.ajpath.2010.10.011
37. Bockle BC, Solder E, Kind S, Romani N, Sepp NT. DC-sign+ CD163+ macrophages expressing hyaluronan receptor LYVE-1 are located within chorion villi of the placenta. Placenta (2008) 29(2):187-92. doi:10.1016/j.placenta.2007.11.003
38. Hsu P, Santner-Nanan B, Dahlstrom J, Fadia M, Chandra A, Peek M, et al. Altered decidual DC-SIGN+ antigen presenting cells and impaired regulatory T cell induction in preeclampsia. Am J Pathol (2012) 181(6):2149-60. doi:10.1016/j.ajpath.2012.08.032
39. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell (2000) 100(5):575-85. doi:10.1016/S0092-8674(00)80693-5
40. Soilleux EJ, Morris LS, Leslie G, Chehimi J, Luo Q, Levroney E, et al. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol (2002) 71(3):445-57.
41. Kammerer U, Eggert AO, Kapp M, McLellan AD, Geijtenbeek TB, Dietl J, et al. Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am J Pathol (2003) 162(3):887-96. doi:10.1016/S0002-9440(10)63884-9
42. Svensson J, Jenmalm MC, Matussek A, Geffers R, Berg G, Ernerudh J. Macrophages at the fetal-maternal interface express markers of alternative activation and are induced by M-CSF and IL-10. J Immunol (2011) 187(7):3671-82. doi:10.4049/jimmunol.1100130
43. Houser BL, Tilburgs T, Hill J, Nicotra ML, Strominger JL. Two unique human decidual macrophage populations. J Immunol (2011) 186(4):2633-42. doi:10.4049/jimmunol.1003153
44. Manavalan JS, Rossi PC, Vlad G, Piazza F, Yarilina A, Cortesini R, et al. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl Immunol (2003) 11(3-4):245-58. doi:10.1016/S0966-3274(03)00058-3
45. Moreau P, Adrian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, et al. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol (1999) 11(5):803-11. doi:10.1093/intimm/11.5.803
46. Hsu P, Santner-Nanan B, Joung S, Peek MJ, Nanan R. Expansion of CD4 HLA-G T cell in human pregnancy is impaired in pre-eclampsia. Am J Reprod Immunol (2014) 71(3):217-28. doi:10.1111/aji.12195
47. Hennessy A, Pilmore HL, Simmons LA, Painter DM. A deficiency of placental IL-10 in preeclampsia. J Immunol (1999) 163(6):3491-5.
48. King A. Uterine leukocytes and decidualization. Hum Reprod Update (2000) 6(1):28-36. doi:10.1093/humupd/6.1.28
49. Carlino C, Stabile H, Morrone S, Bulla R, Soriani A, Agostinis C, et al. Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy. Blood (2008) 111(6):3108-15. doi:10.1182/blood-2007-08-105965
50. Spornitz UM. The functional morphology of the human endometrium and decidua. Adv Anat Embryol Cell Biol (1992) 124:1-99. doi:10.1007/978-3-642-58099-4_1
51. Boyington JC, Brooks AG, Sun PD. Structure of killer cell immunoglobulin-like receptors and their recognition of the class I MHC molecules. Immunol Rev (2001) 181:66-78. doi:10.1034/j.1600-065X.2001.1810105.x
52. King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, et al. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol (2000) 30(6):1623-31. doi:10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M
53. Long EO, Barber DF, Burshtyn DN, Faure M, Peterson M, Rajagopalan S, et al. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Immunol Rev (2001) 181:223-33. doi:10.1034/j.1600-065X.2001.1810119.x
54. Hiby SE, Apps R, Sharkey AM, Farrell LE, Gardner L, Mulder A, et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest (2010) 120(11):4102-10. doi:10.1172/JCI43998
55. Xiong S, Sharkey AM, Kennedy PR, Gardner L, Farrell LE, Chazara O, et al. Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation. J Clin Invest (2013) 123(10):4264-72. doi:10.1172/JCI68991
56. Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, Joosten I, et al. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol (2006) 4(1):e9. doi:10.1371/journal.pbio.0040009
57. Murphy SP, Fast LD, Hanna NN, Sharma S. Uterine NK cells mediate inflammation-induced fetal demise in IL-10-null mice. J Immunol (2005) 175(6):4084-90.
58. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ (2005) 330(7491):565. doi:10.1136/bmj.38380.674340.E0
59. Li DK, Wi S. Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. Am J Epidemiol (2000) 151(1):57-62. doi:10.1093/oxfordjournals.aje.a010122
60. Fan D-X, Duan J, Li M-Q, Xu B, Li D-J, Jin L-P. The decidual gamma-delta T cells up-regulate the biological functions of trophoblasts via IL-10 secretion in early human pregnancy. Clin Immunol (2011) 141(3):284-92. doi:10.1016/j.clim.2011.07.008
61. Tilburgs T, Schonkeren D, Eikmans M, Nagtzaam NM, Datema G, Swings GM, et al. Human decidual tissue contains differentiated CD8+ effector-memory T cells with unique properties. J Immunol (2010) 185(7):4470-7. doi:10.4049/jimmunol.0903597
62. Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, de Groot-Swings GM, et al. Differential distribution of CD4(+)CD25(bright) and CD8(+)CD28(-) T-cells in decidua and maternal blood during human pregnancy. Placenta (2006) 27(Suppl A):S47-53. doi:10.1016/j.placenta.2005.11.008
63. Saito S, Tsukaguchi N, Hasegawa T, Michimata T, Tsuda H, Narita N. Distribution of Th1, Th2, and Th0 and the Th1/Th2 cell ratios in human peripheral and endometrial T cells. Am J Reprod Immunol (1999) 42(4):240-5. doi:10.1111/j.1600-0897.1999.tb00097.x
64. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell (2008) 133(5):775-87. doi:10.1016/j.cell.2008.05.009
65. Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol (2010) 11(1):7-13. doi:10.1038/ni.1818
66. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol (2003) 3(3):199-210. doi:10.1038/nri1027
67. Bilate AM, Lafaille JJ. Induced CD4(+)Foxp3(+) regulatory T Cells in immune tolerance. Annu Rev Immunol (2012) 30:733-58. doi:10.1146/annurev-immunol-020711-075043
68. Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology (2004) 112(1):38-43. doi:10.1111/j.1365-2567.2004.01869.x
69. Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, Fazekas de St Groth B, et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol (2009) 183(11):7023-30. doi:10.4049/jimmunol.0901154
70. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol (2004) 5(3):266-71. doi:10.1038/ni1037
71. Zhao J-X, Zeng Y-Y, Liu Y. Fetal alloantigen is responsible for the expansion of the CD4(+)CD25(+) regulatory T cell pool during pregnancy. J Reprod Immunol (2007) 75(2):71-81. doi:10.1016/j.jri.2007.06.052
72. Kahn DA, Baltimore D. Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance. Proc Natl Acad Sci U S A (2010) 107(20):9299-304. doi:10.1073/pnas.1003909107
73. Rowe JH, Ertelt JM, Xin L, Way SS. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature (2012) 490(7418):102-6. doi:10.1038/nature11462
74. Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler SF, et al. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol (2004) 173(4):2227-30.
75. Arruvito L, Sanz M, Banham AH, Fainboim L. Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol (2007) 178(4):2572-8.
76. Prieto GA, Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology (2006) 118(1):58-65. doi:10.1111/j.1365-2567.2006.02339.x
77. Heikkinen J, Mottonen M, Alanen A, Lassila O. Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol (2004) 136(2):373-8. doi:10.1111/j.1365-2249.2004.02441.x
78. Tilburgs T, Roelen DL, van der Mast BJ, de Groot-Swings GM, Kleijburg C, Scherjon SA, et al. Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol (2008) 180(8):5737-45.
79. Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol (2010) 184(7):3433-41. doi:10.4049/jimmunol.0904028
80. Curotto de Lafaille MA, Lafaille JJ. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity (2009) 30(5):626-35. doi:10.1016/j.immuni.2009.05.002
81. Yadav M, Stephan S, Bluestone JA. Peripherally induced tregs-role in immune homeostasis and autoimmunity. Front Immunol (2013) 4:232. doi:10.3389/fimmu.2013.00232
82. Darrasse-Jeze G, Klatzmann D, Charlotte F, Salomon BL, Cohen JL. CD4+CD25+ regulatory/suppressor T cells prevent allogeneic fetus rejection in mice. Immunol Lett (2006) 102(1):106-9. doi:10.1016/j.imlet.2005.12.001
83. Samstein R, Josefowicz S, Arvey A, Treuting P, Rudensky A. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell (2012) 150(1):29-38. doi:10.1016/j.cell.2012.05.031
84. Lyall F, Robson SC, Bulmer JN. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. Hypertension (2013) 62(6):1046-54. doi:10.1161/HYPERTENSIONAHA.113.01892
85. Malassine A, Frendo JL, Evain-Brion D. A comparison of placental development and endocrine functions between the human and mouse model. Hum Reprod Update (2003) 9(6):531-9. doi:10.1093/humupd/dmg043
86. Prins JR, Boelens HM, Heimweg J, van der Heide S, Dubois AE, van Oosterhout AJ, et al. Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertens (2009) 28(3):300-11. doi:10.1080/10641950802601237
87. Toldi G, Svec P, Vasarhelyi B, Meszaros G, Rigo J, Tulassay T, et al. Decreased number of FoxP3+ regulatory T cells in preeclampsia. Acta Obstet Gynecol Scand (2008) 87(11):1229-33. doi:10.1080/00016340802389470
88. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol (2009) 27:485-517. doi:10.1146/annurev.immunol.021908.132710
89. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity (2006) 24(6):677-88. doi:10.1016/j.immuni.2006.06.002
90. Hatton RD. TGF-beta in Th17 cell development: the truth is out there. Immunity (2011) 34(3):288-90. doi:10.1016/j.immuni.2011.03.009
91. Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol (2010) 40(7):1830-5. doi:10.1002/eji.201040391
92. Toldi G, Rigo J Jr, Stenczer B, Vasarhelyi B, Molvarec A. Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. Am J Reprod Immunol (2011) 66(3):223-9. doi:10.1111/j.1600-0897.2011.00987.x
93. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, et al. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol (2012) 93(2):75-81. doi:10.1016/j.jri.2012.01.006
94. Sharma A, Satyam A, Sharma JB. Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol (2007) 58(1):21-30. doi:10.1111/j.1600-0897.2007.00486.x
95. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 355(10):992-1005. doi:10.1056/NEJMoa055352
96. Mjosberg J, Berg G, Jenmalm MC, Ernerudh J. FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol Reprod (2010) 82(4):698-705. doi:10.1095/biolreprod.109.081208
97. Wang W-J, Hao C-F, Yi L, Yin G-J, Bao S-H, Qiu L-H, et al. Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J Reprod Immunol (2010) 84(2):164-70. doi:10.1016/j.jri.2009.12.003
98. Nakashima A, Ito M, Yoneda S, Shiozaki A, Hidaka T, Saito S. Circulating and decidual Th17 cell levels in healthy pregnancy. Am J Reprod Immunol (2010) 63(2):104-9. doi:10.1111/j.1600-0897.2009.00771.x
99. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science (1990) 248(4952):220-3. doi:10.1126/science.2326636
100. Ellis SA, Palmer MS, McMichael AJ. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. J Immunol (1990) 144(2):731-5.
101. Carosella ED, Gregori S, LeMaoult J. The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells. Blood (2011) 118(25):6499-505. doi:10.1182/blood-2011-07-370742
102. Rouas-Freiss N, Naji A, Durrbach A, Carosella ED. Tolerogenic functions of human leukocyte antigen G: from pregnancy to organ and cell transplantation. Transplantation (2007) 84(1 Suppl):S21-5. doi:10.1097/01.tp.0000269117.32179.1c
103. Favier B, LeMaoult J, Carosella ED. Functions of HLA-G in the immune system. Tissue Antigens (2007) 69(Suppl 1):150-2. doi:10.1111/j.1399-0039.2006.763_6.x
104. Le Discorde M, Moreau P, Sabatier P, Legeais J-M, Carosella ED. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol (2003) 64(11):1039-44. doi:10.1016/j.humimm.2003.08.346
105. Mallet V, Blaschitz A, Crisa L, Schmitt C, Fournel S, King A, et al. HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein. Int Immunol (1999) 11(6):889-98. doi:10.1093/intimm/11.6.889
106. Feger U, Tolosa E, Huang Y-H, Waschbisch A, Biedermann T, Melms A, et al. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood (2007) 110(2):568-77. doi:10.1182/blood-2006-11-057125
107. Huang Y-H, Zozulya AL, Weidenfeller C, Schwab N, Wiendl H. T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible. J Leukoc Biol (2009) 86(2):273-81. doi:10.1189/jlb.1008649
108. LeMaoult J, Caumartin J, Daouya M, Favier B, Le Rond S, Gonzalez A, et al. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood (2007) 109(5):2040-8. doi:10.1182/blood-2006-05-024547
109. Davis DM. Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nat Rev Immunol (2007) 7(3):238-43. doi:10.1038/nri2020
110. Brown R, Kabani K, Favaloro J, Yang S, Ho PJ, Gibson J, et al. CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis. Blood (2012) 120(10):2055-63. doi:10.1182/blood-2012-03-416792
111. Amodio G, Mugione A, Sanchez A, Vigano P, Candiani M, Somigliana E, et al. HLA-G expressing DC-10 and CD4(+) T cells accumulate in human decidua during pregnancy. Hum Immunol. (2013) 74(4):406-11. doi:10.1016/j.humimm.2012.11.031
112. Vacca P, Cantoni C, Vitale M, Prato C, Canegallo F, Fenoglio D, et al. Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression. Proc Natl Acad Sci U S A (2010) 107(26):11918-23. doi:10.1073/pnas.1001749107
113. Miwa N, Hayakawa S, Miyazaki S, Myojo S, Sasaki Y, Sakai M, et al. IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion. Mol Hum Reprod (2005) 11(12):865-70. doi:10.1093/molehr/gah246
114. Mellor AL, Munn DH. Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses. J Reprod Immunol (2001) 52(1-2):5-13. doi:10.1016/S0165-0378(01)00118-8
115. Chen W, Liang X, Peterson AJ, Munn DH, Blazar BR. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol (2008) 181(8):5396-404.
116. Puccetti P, Grohmann U. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol (2007) 7(10):817-23. doi:10.1038/nri2163
117. Kim CJ, McKinnon LR, Kovacs C, Kandel G, Huibner S, Chege D, et al. Mucosal Th17 cell function is altered during HIV infection and is an independent predictor of systemic immune activation. J Immunol (2013) 191(5):2164-73. doi:10.4049/jimmunol.1300829
118. Ziegler SF, Buckner JH. FOXP3 and the regulation of Treg/Th17 differentiation. Microbes Infect (2009) 11(5):594-8. doi:10.1016/j.micinf.2009.04.002
119. Caumartin J, Favier B, Daouya M, Guillard C, Moreau P, Carosella ED, et al. Trogocytosis-based generation of suppressive NK cells. EMBO J (2007) 26(5):1423-33. doi:10.1038/sj.emboj.7601570
120. Huang JF, Yang Y, Sepulveda H, Shi W, Hwang I, Peterson PA, et al. TCR-mediated internalization of peptide-MHC complexes acquired by T cells. Science (1999) 286(5441):952-4. doi:10.1126/science.286.5441.952
121. Stinchcombe JC, Bossi G, Booth S, Griffiths GM. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity (2001) 15(5):751-61. doi:10.1016/S1074-7613(01)00234-5
122. Hudrisier D, Riond J, Mazarguil H, Gairin JE, Joly E. Cutting edge: CTLs rapidly capture membrane fragments from target cells in a TCR signaling-dependent manner. J Immunol (2001) 166(6):3645-9.
123. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell (1993) 75(2):263-74. doi:10.1016/0092-8674(93)80068-P
124. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 66(11):5224-31.
125. Glocker E-O, Kotlarz D, Boztug K, Gertz EM, Schaffer AA, Noyan F, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med (2009) 361(21):2033-45. doi:10.1056/NEJMoa0907206
126. Kotlarz D, Beier R, Murugan D, Diestelhorst J, Jensen O, Boztug K, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology (2012) 143(2):347-55. doi:10.1053/j.gastro.2012.04.045
127. Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich J-M, et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity (2011) 34(4):566-78. doi:10.1016/j.immuni.2011.03.018
128. Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H, et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol (2009) 10(11):1178-84. doi:10.1038/ni.1791